AGP reports for glucose and insulin devices qualitative study: what patients and clinicians want. 

Sci Diabetes Self Manag Care. 2025

Continuous glucose monitoring-measured glucose levels during oral glucose tolerance testing in pregnancy. 

Diabetes Technology & Therapeutics. 2025

Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study. 

Diabetologia. 2025

Glucose-lowering medications, glycemia, and cognitive outcomes: the GRADE Randomized Clinical Trial. 

JAMA internal medicine. 2025

Patient-reported outcomes improve with a virtual diabetes care model that includes continuous glucose monitoring. 

Telemedicine Journal and e-Health. 2025

Weight gain was associated with worsening glycemia and cardiovascular and kidney outcomes in patients with type 2 diabetes independent of diabetes medication in the GRADE randomized controlled trial. 

Diabetes care. 2025

-cell function over time on glycemic outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): differential treatment effects of dual therapy. 

Diabetes care. 2024

Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications. 

Diabetes Technology & Therapeutics. 2024

Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus. 

Diabetes care. 2024

Continuous glucose monitoring-derived differences in pregnancies with and without adverse perinatal outcomes. 

Obstetrics and Gynecology. 2024

Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens. 

Diabetes Technology & Therapeutics. 2024

Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies. 

BMJ open diabetes research & care. 2024

Glycemia reduction in type 2 diabetes-hypoglycemia outcomes: a randomized clinical trial. 

PloS One. 2024

Relationship between average glucose levels and HbA1c differs across racial groups: a substudy of the GRADE randomized trial. 

Diabetes care. 2024

The use of rescue insulin in the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). 

Diabetes care. 2024

Comprehensive telehealth model to support diabetes self-management. 

JAMA network open. 2023

A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G. 

Diabetes Technology & Therapeutics. 2022

A safe and simple algorithm for adding and adjusting mealtime insulin to basal-only therapy. 

Clinical Diabetes. 2022

Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles. 

Journal of Diabetes Science and Technology. 2022

Continuous glucose monitoring in adults with type 1 diabetes with 35 years duration from the DCCT/EDIC Study. 

Diabetes care. 2022

Islet autoimmunity is highly prevalent and associated with diminished β-cell function in patients with type 2 diabetes in the Grade Study. 

Diabetes. 2022

Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes. 

Journal of Diabetes and Its Complications. 2022

A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. 

Lancet (London, England). 2021

Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies. 

PloS One. 2021

Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care. 

Journal of Diabetes Science and Technology. 2021

Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring. 

Journal of the Endocrine Society. 2020

International Diabetes Center: COVID-19 won't stop us from fulfilling our mission. 

Journal of Diabetes Science and Technology. 2020

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. 

Lancet (London, England). 2019

Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen. 

Diabetes Technology & Therapeutics. 2019

Insulin dosing guidance to optimise type 2 diabetes management - authors' reply. 

Lancet (London, England). 2019

Rationale and design for a GRADE substudy of continuous glucose monitoring. 

Diabetes Technology & Therapeutics. 2019

The relationships between time in range, hyperglycemia metrics, and HbA1c. 

Journal of Diabetes Science and Technology. 2019

Can a tool that automates insulin titration be a key to diabetes management?. 

Diabetes Technology & Therapeutics. 2012

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. 

Archives of Internal Medicine. 2011

Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. 

Diabetes care. 2008

Creatinine clearance and blood pressure: a 34-year circadian study. 

Clinica Terapeutica. 2008

Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control. 

Diabetes Technology & Therapeutics. 2005

Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. 

Diabetes care. 2003

Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care [poster]

2019

Comparing patch vs.pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles [poster]

2018

Optimizing basal-bolus therapy in T2D—a randomized controlled trial comparing bolus insulin delivery using an insulin patch vs. an insulin pen [poster]

2018

Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice [review]. 

Diabetes Technology & Therapeutics. 2019

Standardized report for pattern recognition: role of the Ambulatory Glucose Profile (AGP) in closed loop therapy [presentation], National Institutes of Health Fourth Artificial Pancreas Workshop: Testing and Adoption of Current and Emerging Technologies